Featured · Weight loss5 min read
Wegovy and Hair Loss: Causes, Subtypes, and Clinical Evidence
Understand the link between Wegovy, rapid weight loss, and hair shedding, including clinical subtypes, regulatory facts, and clinician questions.
The Leland Journal
Clear answers on weight, energy and sexual health.
Plain-language guides so you can make informed decisions before you ever fill out an intake.
Latest articles
ComparisonWeight loss5 min read
Comparing Tirzepatide and Semaglutide: Clinical Evidence and Regulatory Safety
An educational overview of tirzepatide and semaglutide, comparing real-world efficacy, adverse event profiles, economic evaluations, and FDA compounding guidance.
Weight loss5 min read
Understanding Semaglutide Onset, Risks, and Treatment Timelines
Learn about semaglutide onset timelines, dosing titration considerations, gastrointestinal risks, and the regulatory distinctions between GLP-1 options.
ComparisonWeight loss6 min read
Tirzepatide vs. Semaglutide: Comparing Efficacy, Safety, and Real-World Evidence
Compare tirzepatide and semaglutide on weight loss, blood sugar control, real-world adherence, side effects, and important FDA safety alerts regarding compounded versions.
Weight loss6 min read
Navigating GLP-1 Treatment: Safety, Approval Status, and Long-Term Weight Maintenance
An educational guide to semaglutide, FDA approval distinctions, safety risks of compounded drugs, and clinical strategies for long-term weight maintenance.
Weight loss5 min read
Understanding Semaglutide: Timeline, Mechanism, and FDA Safety Guidance
An educational overview of semaglutide research, patient experiences with food noise reduction, potential side effects, and FDA safety guidance on compounded options.
ComparisonWeight loss5 min read
Tirzepatide vs Semaglutide: Side Effects and Real-World Weight Loss Differences
Compare real-world side effects, weight loss outcomes, and regulatory considerations between semaglutide and tirzepatide for obesity management.
Weight loss5 min read
Understanding Semaglutide Timelines, Clinical Evidence, and Safety Guidelines
Learn about semaglutide timelines, clinical findings on weight and pain, patient preferences, gastrointestinal safety risks, and FDA guidance on compounded GLP-1 drugs.
ComparisonWeight loss6 min read
Comparing Semaglutide and Tirzepatide: Efficacy, Safety, and FDA Guidance
Explore clinical trial findings, real-world evidence, cardiovascular associations, and important FDA safety facts on semaglutide versus tirzepatide.
Weight loss3 min read
What actually drives the price of GLP-1 medication?
A recurring GLP-1 price is several costs stacked into one number — the medication itself, the clinical oversight around it, and the pharmacy logistics behind it. Here's what's actually in the stack.
(updated )
Weight loss3 min read
Semaglutide vs. tirzepatide: what actually differs between them
Both are once-weekly GLP-1 injections, but they aren't the same drug wearing two names. Here's what's mechanically different between semaglutide and tirzepatide, and what to actually ask a clinician when deciding between them.
(updated )
Weight loss3 min read
GLP-1 side effects: what to expect, and how they're typically managed
Nausea and other digestive side effects are common when starting a GLP-1 medication, especially around a dose increase. Here's what's typical, why it happens, and the general approach clinicians commonly discuss for making it more tolerable.
Side by side
Compare treatments
Where we are licensed